The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma A Jordan, R Scholz, K Maier-Hauff, FKH van Landeghem, N Waldoefner, ... Journal of neuro-oncology 78, 7-14, 2006 | 607 | 2006 |
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles FKH van Landeghem, K Maier-Hauff, A Jordan, KT Hoffmann, ... Biomaterials 30 (1), 52-57, 2009 | 436 | 2009 |
Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency H Krude, B Schütz, H Biebermann, A Von Moers, D Schnabel, H Neitzel, ... The Journal of clinical investigation 109 (4), 475-480, 2002 | 427 | 2002 |
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas AS Guerreiro Stucklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, ... Nature Communications 10 (1), 4343, 2019 | 251 | 2019 |
Decreased hemispheric Aquaporin-4 is linked to evolving brain edema following controlled cortical impact injury in rats KL Kiening, FKH Van Landeghem, S Schreiber, UW Thomale, ... Neuroscience letters 324 (2), 105-108, 2002 | 247 | 2002 |
Microglia express GABAB receptors to modulate interleukin release SA Kuhn, FKH van Landeghem, R Zacharias, K Färber, A Rappert, ... Molecular and Cellular Neuroscience 25 (2), 312-322, 2004 | 237 | 2004 |
A role for β-melanocyte-stimulating hormone in human body-weight regulation H Biebermann, TR Castañeda, F van Landeghem, A von Deimling, ... Cell metabolism 3 (2), 141-146, 2006 | 226 | 2006 |
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ... Journal of clinical oncology 34 (21), 2468-2477, 2016 | 198 | 2016 |
Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the γ2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase … B Burwinkel, JW Scott, C Bührer, FKH Van Landeghem, GF Cox, ... The American Journal of Human Genetics 76 (6), 1034-1049, 2005 | 186 | 2005 |
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas ASG Stucklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, C Li, ... Nature communications 10, 2019 | 173 | 2019 |
Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat FKH Van Landeghem, JF Stover, I Bechmann, W Brück, A Unterberg, ... Glia 35 (3), 167-179, 2001 | 172 | 2001 |
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis M Hasselblatt, C Thomas, V Hovestadt, D Schrimpf, P Johann, S Bens, ... Acta neuropathologica 132, 149-151, 2016 | 140 | 2016 |
Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas F Stockhammer, M Plotkin, H Amthauer, FKH Van Landeghem, ... Journal of neuro-oncology 88, 205-210, 2008 | 116 | 2008 |
Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition L Nobre, M Zapotocky, V Ramaswamy, S Ryall, J Bennett, D Alderete, ... JCO precision oncology 4, 561-571, 2020 | 114 | 2020 |
In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy A Shatunov, M Olivé, Z Odgerel, C Stadelmann-Nessler, K Irlbacher, ... European journal of human genetics 17 (5), 656-663, 2009 | 88 | 2009 |
CT7 (MAGE‐C1) antigen expression in normal and neoplastic tissues AA Jungbluth, YT Chen, KJ Busam, K Coplan, D Kolb, K Iversen, ... International journal of cancer 99 (6), 839-845, 2002 | 85 | 2002 |
Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy B Kerst, D Mennerich, M Schuelke, G Stoltenburg-Didinger, A von Moers, ... Neuromuscular Disorders 10 (8), 572-577, 2000 | 69 | 2000 |
Clinicopathological spectrum of bilirubin encephalopathy/kernicterus S Das, FKH van Landeghem Diagnostics 9 (1), 24, 2019 | 67 | 2019 |
Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1‐deficient non‐rhabdoid tumor with favorable long‐term outcome PD Johann, V Hovestadt, C Thomas, A Jeibmann, K Heß, S Bens, F Oyen, ... Brain Pathology 27 (4), 411-418, 2017 | 65 | 2017 |
Erythropoietin-receptor gene regulation in neuronal cells I Wallach, J Zhang, A Hartmann, FKH van Landeghem, A Ivanova, M Klar, ... Pediatric research 65 (6), 619-624, 2009 | 62 | 2009 |